Sign In
Buy ALEC
$1.78
-0.175 (-8.97%)
At Close: Jun 03, 2026
Alector (ALEC) Reports Q1 Loss, Lags Revenue Estimates
08:12pm, Thursday, 07'th May 2026
Alector (ALEC) came out with a quarterly loss of $0.21 per share versus the Zacks Consensus Estimate of a loss of $0.35. This compares to a loss of $0.41 per share a year ago.
Alector Reports First Quarter 2026 Financial Results and Provides Business Update
04:05pm, Thursday, 07'th May 2026
Advancing the Alector Brain Carrier (ABC) platform across multiple therapeutic modalities, including antibodies, enzymes, and siRNA, with continued progress across AL037/AL137 (ABC-enabled antibody fo
Will Alector (ALEC) Report Negative Q1 Earnings? What You Should Know
11:00am, Thursday, 07'th May 2026
Alector (ALEC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
--Independent data monitoring committee (IDMC) determined the trial unlikely to meet primary endpoint – --Alector remains focused on advancing its pipeline of novel ABC-enabled candidates, includi
Alector (ALEC)'s Technical Outlook is Bright After Key Golden Cross
10:55am, Tuesday, 10'th Mar 2026
After reaching an important support level, Alector, Inc. (ALEC) could be a good stock pick from a technical perspective. ALEC recently experienced a "golden cross" event, which saw its 50-day simple m
Wall Street Turns Bullish on HIMS, TDOC and ALEC as Partnerships Reshape Risk Profiles
10:09am, Tuesday, 10'th Mar 2026
Three health-technology names are drawing fresh analyst attention this week as strategic partnerships and business pivots reframe the risk-reward calculus for each.
Alector, Inc. (ALEC) Presents at TD Cowen 46th Annual Health Care Conference Transcript
05:45pm, Friday, 06'th Mar 2026
Alector, Inc. (ALEC) Presents at TD Cowen 46th Annual Health Care Conference Transcript
Alector (ALEC) Reports Q4 Loss, Beats Revenue Estimates
08:25pm, Wednesday, 25'th Feb 2026
Alector (ALEC) came out with a quarterly loss of $0.34 per share versus the Zacks Consensus Estimate of a loss of $0.39. This compares to a loss of $0.02 per share a year ago.
Alector Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
04:05pm, Wednesday, 25'th Feb 2026
Advancing the Alector Brain Carrier (ABC) platform across multiple therapeutic modalities, including antibodies, enzymes, and siRNA, with continued progress across AL137 (ABC-enabled anti-amyloid anti
Alector to Participate in the TD Cowen 46th Annual Health Care Conference
08:00am, Tuesday, 24'th Feb 2026
SOUTH SAN FRANCISCO, Calif., Feb. 24, 2026 (GLOBE NEWSWIRE) -- Alector, Inc. (Nasdaq: ALEC), a clinical-stage biotechnology company focused on developing therapies to counteract the devastating progre
Alector (NASDAQ:ALEC) and Milestone Pharmaceuticals (NASDAQ:MIST) Critical Review
01:44am, Monday, 02'nd Feb 2026
Milestone Pharmaceuticals (NASDAQ: MIST - Get Free Report) and Alector (NASDAQ: ALEC - Get Free Report) are both small-cap medical companies, but which is the better stock? We will contrast the two co
INVESTOR ALERT: Levi & Korsinsky is Investigating Alec Stock After its Phase 3 INFRONT-3 Clinical Trial Misses Co-Primary Endpoint
06:06pm, Thursday, 29'th Jan 2026
NEW YORK, Jan. 29, 2026 /PRNewswire/ -- Levi & Korsinsky, LLP is investigating Alector, Inc. (NASDAQ: ALEC) following the Company's announcement of topline results from its Phase 3 INFRONT-3 trial, e
Alector, Inc. (NASDAQ:ALEC) Given Average Rating of “Reduce” by Analysts
01:49am, Wednesday, 31'st Dec 2025
Alector, Inc. (NASDAQ: ALEC - Get Free Report) has been assigned an average rating of "Reduce" from the nine analysts that are currently covering the stock, Marketbeat.com reports. Two equities resear
Short Interest in Alector, Inc. (NASDAQ:ALEC) Expands By 35.9%
05:14am, Tuesday, 30'th Dec 2025
Alector, Inc. (NASDAQ: ALEC - Get Free Report) was the target of a significant growth in short interest in December. As of December 15th, there was short interest totaling 6,319,929 shares, a growth o
Alector (NASDAQ:ALEC) Trading 4.8% Higher – Here’s Why
01:51am, Tuesday, 30'th Dec 2025
Alector, Inc. (NASDAQ: ALEC - Get Free Report)'s stock price was up 4.8% during trading on Monday. The stock traded as high as $1.53 and last traded at $1.52. Approximately 1,576,232 shares traded han
